Polymyositis Completed Phase 2 Trials for Corticotropin (DB01285)

IndicationStatusPhase
DBCOND0013509 (Polymyositis)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01906372Acthar in Treatment of Refractory Dermatomyositis and PolymyositisTreatment